サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629216

血流動態補正装置の世界市場：種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Hemodynamic Flow Alteration Devices Market, By Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 395 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
血流動態補正装置の世界市場：種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年12月30日
発行: AnalystView Market Insights
ページ情報: 英文 395 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

血流動態補正装置の市場規模は2023年に8億567万米ドルとなり、2024年から2032年にかけてCAGR 8.5%で拡大

血流動態補正装置の市場力学

心不全や虚血性心疾患などの心血管疾患有病率の増加が市場需要を促進

心血管系疾患 (CVD)、特に心不全や虚血性心疾患の有病率の増加が、血流動態補正装置の需要拡大を牽引しています。人口の高齢化に伴い、心不全や虚血性心疾患の発生率は上昇の一途をたどっています。世界保健機関 (WHO) によると、CVDは世界の死因の第1位で、世界の全死亡者の約32%を占めています。このような心臓病による負担の増大により、心臓の機能をサポートし、患者の生存率を向上させる医療機器の緊急の必要性が生じています。補助人工心臓 (VAD)、大動脈内バルーンポンプ (IABP)、体外膜酸素療法 (ECMO) などの機器は、患者の安定化と危機的状況での循環強化に極めて重要です。これらの機器は、臓器不全を予防し、酸素供給を行い、機械的サポートを提供することで、患者に回復やより確実な治療に必要な時間を与えます。さらに、これらの技術の進歩により、デバイスはより効果的で利用しやすくなり、その普及はさらに進んでいます。これらの機器に対する需要の高まりは、CVDが依然として死因の第1位であり、毎年数百万人に影響を及ぼしているという事実によって浮き彫りになった、世界の心血管負担の増大に対処する緊急の必要性によってもたらされています。

血流動態補正装置市場：主な考察

  • 弊社のリサーチアナリストの分析によると、世界市場は予測期間 (2024-2032年) に約8.5%のCAGRで毎年成長すると予測されています。
  • 市場セグメンテーションに基づくと、慢性完全閉塞装置が2023年に最大市場シェアを示すと予測されます。
  • 用途別では、2023年に心臓デバイスが主要タイプでした。
  • 地域別では、北米が2023年に収益を上げる主要市場です。

血流動態補正装置市場：セグメンテーション分析

血流動態補正装置の世界市場は、種類、用途、最終用途、地域に基づいてセグメント化されます。

市場は種類別に2つに分類されます：すなわち、塞栓防止装置と慢性完全閉塞装置です。慢性完全閉塞装置は、標準的な血管形成術では対処できない複雑な冠動脈閉塞患者の治療に重要な役割を果たすため、市場を独占しています。冠動脈疾患の有病率の増加は、低侵襲処置の需要の高まりと相まって、患者の転帰に大きな改善をもたらし、合併症発生率が低いCTOデバイスの採用を後押ししています。

市場は用途別に3つのカテゴリーに分類されます：心臓用デバイス、脳循環用デバイス、末梢循環用デバイスです。冠動脈疾患、心不全、不整脈などの心血管疾患の有病率が増加しており、患者の転帰を改善するために高度な医療介入が必要であることから、心臓用デバイスが市場を独占しており、予測期間中もその優位性は維持されるとみられます。

血流動態補正装置市場：地域別分析

血流動態補正装置市場は、医療ニーズの高まりと技術の進歩により、さまざまな地域で大きな成長を遂げています。北米、特に米国は、高い医療費、高齢化人口の多さ、先進医療技術の採用増加により、市場で支配的な地位を占めています。同地域の強固な医療インフラは、補助人工心臓 (VAD)、大動脈内バルーンポンプ (IABP)、体外膜酸素化 (ECMO) システムなどの機器の普及を支えています。また、ドイツ、英国、フランスなどの国々が医療イノベーションに投資しているため、これらの救命デバイスの採用が増加しています。アジア太平洋は、心血管疾患の有病率の増加、医療アクセスの拡大、医療ツーリズムの増加により、予測期間中に最も高い成長率を示すと予想されます。日本、中国、インドなどの国々では、政府の取り組みや医療インフラの改善が市場拡大に寄与しており、これらの機器の採用率が高まっています。心臓病に対する意識の高まりとこの分野における技術の進歩は、今後も血流動態補正装置の世界の普及を促進すると思われます。

血流動態補正装置市場：競合情勢

血流動態補正装置市場の競合情勢は、市場ポジションを維持するために、技術革新、戦略的パートナーシップ、地域拡大に注力する複数の主要企業の存在によって特徴付けられます。各社は、装置の効率と有効性を高めるための研究開発への投資を増やしており、特に侵襲性が低く使いやすいソリューションによって患者の予後を改善することに重点を置いています。製品イノベーションに加え、合併、買収、提携は、製品ポートフォリオを拡大し、新市場に参入するための一般的な戦略です。市場はまた、ウェアラブルデバイスや遠隔モニタリングソリューションのような先進技術を提供する企業との競争も激化しており、これらの企業はその利便性とデジタルヘルスプラットフォームとの統合により支持を集めています。さらに、医療提供者や医療機関がこれらの機器の導入における重要な意思決定者となりつつあり、各社が自社製品の臨床的利点、費用対効果、長期的な優位性を実証しようとするため、競争が激化しています。血行動態サポート機器に対する需要が世界的に増加し続ける中、各社は急性および慢性心血管系疾患の両方に対応する包括的なソリューションの提供に注力し、競合の力学は進化していくと思われます。

目次

第1章 血流動態補正装置市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 血流動態補正装置の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 血流動態補正装置市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 血流動態補正装置市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 血流動態補正装置の市場情勢

  • 血流動態補正装置の市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 血流動態補正装置市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • 塞栓防止装置
    • 慢性完全閉塞装置

第8章 血流動態補正装置市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 心臓デバイス
    • 脳血流デバイス
    • 末梢循環装置

第9章 血流動態補正装置市場：製品種類別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 外来手術センター
    • 病院・クリニック

第10章 血流動態補正装置市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：血流動態補正装置業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Abiomed, Inc.
    • Medtronic, Inc.
    • Teleflex Incorporated
    • Edwards Lifesciences Corporation
    • Getinge Group
    • Fresenius Medical Care AG &Co. KGaA
    • LivaNova PLC
    • CardiacAssist, Inc.
    • Terumo Corporation
    • BiVACOR, Inc.
    • SynCardia Systems, LLC
    • Johnson &Johnson
    • Boston Scientific Corporation
    • Philips Healthcare
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4552

REPORT HIGHLIGHT

Hemodynamic Flow Alteration Devices Market size was valued at USD 805.67 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

Hemodynamic flow alteration devices are medical devices designed to modify or support blood circulation in patients with compromised hemodynamic function. These devices include intra-aortic balloon pumps (IABPs), ventricular assist devices (VADs), extracorporeal membrane oxygenation (ECMO), and various vascular grafts and stents. They are primarily used in patients with heart failure, shock, or those undergoing complex surgeries where maintaining optimal blood flow is critical. The need for these devices arises from the increasing prevalence of cardiovascular diseases, which require advanced interventions to sustain life, improve circulation, and support organs until they recover or until more definitive treatment is performed. The importance of hemodynamic flow alteration devices is underscored by their ability to provide temporary circulatory support, thus preventing organ failure and improving survival rates. Additionally, these devices are essential in critical care settings, where they help stabilize patients, provide oxygenation, and reduce the strain on the heart, allowing time for healing or recovery

Hemodynamic Flow Alteration Devices Market- Market Dynamics

Increasing prevalence of cardiovascular diseases, including heart failure and ischemic heart conditions to propel market demand

The increasing prevalence of cardiovascular diseases (CVD), particularly heart failure and ischemic heart conditions, is driving the growing demand for hemodynamic flow alteration devices. As populations age, the incidence of heart failure and ischemic heart disease continues to rise. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for approximately 32% of all deaths worldwide. This increasing burden of heart disease creates an urgent need for medical devices that support heart function and improve patient survival. Devices like ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO) are crucial in stabilizing patients and enhancing circulation in critical situations. These devices prevent organ failure, provide oxygenation, and offer mechanical support, giving patients the time they need for recovery or more definitive treatment. Furthermore, advancements in these technologies are making devices more effective and accessible, further increasing their adoption. The rising demand for these devices is driven by the urgent need to address the growing global cardiovascular burden, highlighted by the fact that CVD remain the number one cause of death, impacting millions of individuals annually.

Hemodynamic Flow Alteration Devices Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)
  • Based on Type segmentation, Chronic Total Occlusion Device was predicted to show maximum market share in the year 2023
  • Based on Application segmentation, Cardiac Devices was the leading type in 2023
  • Based on region, North America was the leading revenue generator in 2023

Hemodynamic Flow Alteration Devices Market- Segmentation Analysis:

The Global Hemodynamic Flow Alteration Devices Market is segmented based on Type, Application, End-Use and Region.

The market is divided into two categories based on type: Embolic Protection Device, and Chronic Total Occlusion Device. The Chronic Total Occlusion Device dominate the market due to its critical role in treating patients with complex coronary artery blockages that cannot be addressed through standard angioplasty. The increasing prevalence of coronary artery disease, coupled with the growing demand for minimally invasive procedures, drives the adoption of CTO devices, which offer significant improvements in patient outcomes and are associated with lower complication rates.

The market is divided into three categories based on Application: Cardiac Devices, Cerebral Flow Devices, and Peripheral Circulation Devices. Cardiac Devices dominate the market and are likely to maintain their dominance during the forecast period due to the increasing prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias, which require advanced medical interventions to improve patient outcomes.

Hemodynamic Flow Alteration Devices Market- Geographical Insights

The hemodynamic flow alteration devices market is experiencing significant growth across different regions, driven by rising healthcare needs and technological advancements. North America, particularly the United States, holds a dominant position in the market due to high healthcare spending, a large ageing population, and increased adoption of advanced medical technologies. The region's robust healthcare infrastructure supports the widespread use of devices such as ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO) systems. Europe also presents strong growth potential, with countries like Germany, the UK, and France investing in healthcare innovations, leading to increased adoption of these life-saving devices. The Asia-Pacific region is expected to experience the highest growth rate during the forecast period, driven by the growing prevalence of cardiovascular diseases, expanding healthcare access, and a rise in medical tourism. Countries like Japan, China, and India are adopting these devices at a growing rate, with government initiatives and improving healthcare infrastructure contributing to the market's expansion. The rising awareness of heart diseases and technological advancements in the field are likely to continue driving the adoption of hemodynamic flow alteration devices globally.

Hemodynamic Flow Alteration Devices Market- Competitive Landscape:

The competitive landscape of the hemodynamic flow alteration devices market is characterized by the presence of several key players focusing on innovation, strategic partnerships, and geographic expansion to maintain their market position. Companies are increasingly investing in research and development to enhance the efficiency and effectiveness of their devices, with a particular emphasis on improving patient outcomes through less invasive and more user-friendly solutions. In addition to product innovation, mergers, acquisitions, and collaborations are common strategies to expand product portfolios and enter new markets. The market is also seeing increased competition from companies offering advanced technologies like wearable devices and remote monitoring solutions, which are gaining traction due to their convenience and integration with digital health platforms. Furthermore, healthcare providers and institutions are becoming key decision-makers in the adoption of these devices, driving competition as companies seek to demonstrate the clinical benefits, cost-effectiveness, and long-term advantages of their offerings. As the demand for hemodynamic support devices continues to rise globally, the competitive dynamics will evolve, with companies focusing on delivering comprehensive solutions that address both acute and chronic cardiovascular conditions.

Recent Developments:

  • In February 2022, Philips enhanced its Lumify handheld ultrasound system by incorporating Pulse Wave Doppler, allowing healthcare professionals to assess hemodynamics and blood flow in real time, improving diagnostic capabilities across various medical specialities. The addition of Pulse Wave Doppler, combined with other advanced features like B-lines software, expands the utility of Lumify, enabling faster, more accurate assessments of heart, lung, and vascular conditions, especially in point-of-care settings such as emergency and obstetric care.
  • In June 2024, Elixir Medical's DynamX Bioadaptor System was granted FDA Breakthrough Device designation, which allows for more efficient regulatory review. The system aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with ischemic heart disease, demonstrating significant benefits over current treatment options, as seen in recent trial results.
  • In May 2022, Georgia Tech researchers developed a wireless, implantable vascular monitoring system, which consists of a smart stent and printed soft sensors capable of real-time hemodynamic monitoring. This innovative device provides continuous data on arterial pressure, pulse, and blood flow without the need for batteries or traditional circuits, aiming to improve the diagnosis and treatment of vascular diseases, such as hypertension and atherosclerosis, while potentially replacing costly and invasive imaging techniques.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abiomed, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Getinge Group
  • Fresenius Medical Care AG & Co. KGaA
  • LivaNova PLC
  • CardiacAssist, Inc.
  • Terumo Corporation
  • BiVACOR, Inc.
  • SynCardia Systems, LLC
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Philips Healthcare
  • Others

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Embolic Protection Device
  • Chronic Total Occlusion Device
  • Others

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Devices
  • Cerebral Flow Devices
  • Peripheral Circulation Devices

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Ambulatory Surgical Centers
  • Hospitals & Clinics

GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemodynamic Flow Alteration Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemodynamic Flow Alteration Devices Market Snippet by Type
    • 2.1.2. Hemodynamic Flow Alteration Devices Market Snippet by Application
    • 2.1.3. Hemodynamic Flow Alteration Devices Market Snippet by End-Use
    • 2.1.4. Hemodynamic Flow Alteration Devices Market Snippet by Country
    • 2.1.5. Hemodynamic Flow Alteration Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemodynamic Flow Alteration Devices Key Market Trends

  • 3.1. Hemodynamic Flow Alteration Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemodynamic Flow Alteration Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemodynamic Flow Alteration Devices Market Opportunities
  • 3.4. Hemodynamic Flow Alteration Devices Market Future Trends

4. Hemodynamic Flow Alteration Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemodynamic Flow Alteration Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemodynamic Flow Alteration Devices Market Landscape

  • 6.1. Hemodynamic Flow Alteration Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemodynamic Flow Alteration Devices Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Embolic Protection Device
    • 7.1.3. Chronic Total Occlusion Device

8. Hemodynamic Flow Alteration Devices Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Cardiac Devices
    • 8.1.3. Cerebral Flow Devices
    • 8.1.4. Peripheral Circulation Devices

9. Hemodynamic Flow Alteration Devices Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2. Ambulatory Surgical Centers
    • 9.1.3. Hospitals & Clinics

10. Hemodynamic Flow Alteration Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hemodynamic Flow Alteration Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hemodynamic Flow Alteration Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Hemodynamic Flow Alteration Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abiomed, Inc.
    • 11.2.2. Medtronic, Inc.
    • 11.2.3. Teleflex Incorporated
    • 11.2.4. Edwards Lifesciences Corporation
    • 11.2.5. Getinge Group
    • 11.2.6. Fresenius Medical Care AG & Co. KGaA
    • 11.2.7. LivaNova PLC
    • 11.2.8. CardiacAssist, Inc.
    • 11.2.9. Terumo Corporation
    • 11.2.10. BiVACOR, Inc.
    • 11.2.11. SynCardia Systems, LLC
    • 11.2.12. Johnson & Johnson
    • 11.2.13. Boston Scientific Corporation
    • 11.2.14. Philips Healthcare
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us